Azerbaijan vs Myanmar: Cause of death, by non-communicable diseases, female
Azerbaijan
66.8%
in 2021
Myanmar
67.1%
in 2021
Azerbaijan rank
102nd
Myanmar rank
100th
Cause of death, by non-communicable diseases, female over time
- Azerbaijan
- Myanmar
How they compare
Myanmar currently reports 67.1% against 66.8% in Azerbaijan, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Azerbaijan ahead.
Azerbaijan ranks 102nd and Myanmar ranks 100th of 185 countries.
Azerbaijan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 80.7% | 55.7% | 25.1% | Azerbaijan |
| 2010s | 89.7% | 70.6% | 19.1% | Azerbaijan |
| 2020s | 71.9% | 71.0% | 0.9% | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Azerbaijan or Myanmar?
- Myanmar, at 67.1% against 66.8% in Azerbaijan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Azerbaijan and Myanmar?
- 0.3%, with Myanmar ahead.
- How many years of comparable data are there for Azerbaijan and Myanmar?
- 6 years are reported by both, from 2000 to 2021.
- How do Azerbaijan and Myanmar rank globally for cause of death, by non-communicable diseases, female?
- Azerbaijan ranks 102nd and Myanmar ranks 100th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.